Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine by Ronald F van Vollenhoven, Maarten Boers, Willem Lems, Mike Nurmohamed

Get full text

Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes by Giulia Frazzei, Giulia Frazzei, Ronald F. van Vollenhoven, Ronald F. van Vollenhoven, Brigit A. de Jong, Sarah E. Siegelaar, Dirkjan van Schaardenburg, Dirkjan van Schaardenburg

Get full text

Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND by Ronald F van Vollenhoven, Roy Fleischmann, Stephen Hall, Yanna Song, Sebastian Meerwein, Alvin F Wells, Oishi Tanjinatus

Get full text

Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials. by Emilia Quattrocchi, Mikkel Østergaard, Peter C Taylor, Ronald F van Vollenhoven, Myron Chu, Stephen Mallett, Hayley Perry, Regina Kurrasch

Get full text

Levelling the playing field of RMD research across Europe to address patients’ needs: the emerging EULAR Research Centre by Ronald F van Vollenhoven, Anna Molto, Iain B McInnes, Rik Lories, Andrew Cope, Dirk Elewaut, Katja Reuter, Carina Haupt

Get full text

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence by Ronald F van Vollenhoven, Alain Cornet, Jeanette Andersen, Zgjim Osmani, Thijs J Schrama, Wendy Zacouris-Verweij, Susan Frankel, Irene E M Bultink

Get full text

Correction: Targeting DORIS Remission and LLDAS in SLE: A Review by Agner R. Parra Sánchez, Ronald F. van Vollenhoven, Eric F. Morand, Ian N. Bruce, Rangi Kandane-Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al-Mossawi, Alessandro Sorrentino

Get full text

Targeting DORIS Remission and LLDAS in SLE: A Review by Agner R. Parra Sánchez, Ronald F. van Vollenhoven, Eric F. Morand, Ian N. Bruce, Rangi Kandane-Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al-Mossawi, Alessandro Sorrentino

Get full text

Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review by Ronald F van Vollenhoven, Manuel Francisco Ugarte-Gil, Bernardo A Pons-Estel, George Bertsias, Cristina Reátegui-Sokolova, Claudia Mendoza-Pinto, Guillermo J. Pons-Estel, Graciela S. Alarcon

Get full text

P165 Kinetics of mucocutaneous and musculoskeletal responses to deucravacitinib in patients with systemic lupus erythematosus (SLE) in the phase 2 PAISLEY trial by Joseph F Merola, Subhashis Banerjee, Eric Morand, Piotr Leszczyński, Marilyn Pike, Ronald F van Vollenhoven, Coburn Hobar, Kathryn H Dao, Samantha Pomponi, Matthew J Colombo, Ravi Koti, Thomas Wegman

The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study by Ronald F van Vollenhoven, Danielle M Gerlag, Karen I Maijer, Sander W Tas, Niek de Vries, Paul P Tak, Robert B M Landewé, Lisa G M van Baarsen, Giulia Frazzei, Sophie H M Cramer

Get full text

Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective by Victoria P Werth, Ronald F van Vollenhoven, Kenneth Kalunian, Karen Costenbader, Eric F Morand, Peter Lipsky, Christopher Reed, Laura Eve Schanberg, Zahi Touma, Anca D Askanase, Lauren Bloch, Timothy Franson, L Inês, Joy Buie, MaryBeth Son

Get full text

Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study by Ronald F van Vollenhoven, Merete Lund Hetland, Till Uhlig, Espen A Haavardsholm, Dan Nordström, Aleksandra Antovic, Mikkel Østergaard, Michael T Nurmohamed, Bjorn Gudbjornsson, Gerður Gröndal, Kim Hørslev-Petersen, Anna Rudin, Jon Lampa, Kristina Lend, Daisy Vedder, Marte Schrumpf Heiberg, Bas Dijkshoorn, Romy Hansildaar, Nida Soutari

Get full text

Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study by Ronald F van Vollenhoven, Merete Lund Hetland, Till Uhlig, Espen A Haavardsholm, Dan Nordström, Mikkel Østergaard, Michael T Nurmohamed, Sizheng Steven Zhao, Alf Kastbom, Bjorn Gudbjornsson, Meliha Crnkic Kapetanovic, Gerður Gröndal, Yuan Zhang, Kim Hørslev-Petersen, Anna Rudin, Jon Lampa, Kristina Lend, Tuulikki Sokka-Isler, Annika Söderbergh, Milad Rizk, Cristina Maglio, Marte Schrumpf Heiberg, Violetta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima

Get full text

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study by Ronald F van Vollenhoven, Sander W Tas, Taco W Kuijpers, Maarten Boers, Michael T Nurmohamed, Gertjan Wolbink, Irene E van der Horst-Bruinsma, Theo Rispens, Willem Lems, Alexandre Voskuyl, Carla A Wijbrandts, S Marieke van Ham, Martijn Gerritsen, Erik H Vogelzang, Luuk Wieske, Laura Boekel, Femke Hooijberg, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Filip Eftimov, Laura Y Kummer, PJ Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff

Get full text

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network by Ronald F van Vollenhoven, Bente Glintborg, Merete Lund Hetland, Ulf Lindström, Brigitte Michelsen, Elsa Vieira-Sousa, Florenzo Iannone, Eirik Klami Kristianslund, Dan Nordström, Karel Pavelka, Ziga Rotar, Maria Jose Santos, Catalin Codreanu, Gary J Macfarlane, Mikkel Østergaard, Michael T Nurmohamed, Jiri Vencovsky, Rosario Foti, Bjorn Gudbjornsson, Matija Tomšič, Lykke Midtbøll Ørnbjerg, Adrian Ciurea, Árni Jón Geirsson, Irene van der Horst-Bruinsma, Michael S Nissen, Ovidiu Rotariu, Isabel Castrejón, Johan K Wallman, Marleen van de Sande, Anne G Loft, Pasoon Hellamand, Thomas Klausch, Anna Mari Hokkanen, Corina Mogosan, Lucia Otero-Varela, Semih Gulle, Berrin Zengin

Get full text

102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort by Joan T Merrill, Michelle Petri, David A Isenberg, Daniel J Wallace, Susan Manzi, Cynthia Aranow, Jill Buyon, Rosalind Ramsey-Goldman, Anca Askanase, Ian N Bruce, Guillermo Ruiz-Irastorza, Ellen M Ginzler, Graciela S Alarcón, John G Hanly, Murray B Urowitz, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Anisur Rahman, Mary Anne Dooley, Paul R Fortin, Dafna D Gladman, Meggan Mackay, Andreas Jönsen, Sam Lim, Murat Inanc, Diane L Kamen, Christine A Peschken, Søren Jacobsen, Jorge Sanchez-Guerrero, Marvin J Fritzler, Ann E Clarke, Sasha Bernatsky, Kenneth C Kalunian, Eugene Krustev, May Y Choi, Ronald F van Vollenhoven, Katherine Buhler, Ricky Chin, Francesca Cardwell

Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus by Joan T Merrill, Ronald F van Vollenhoven, Daniel J Wallace, Susan Manzi, Cynthia Aranow, Anca Askenase, Michelle A Petri, Jill Buyon, Rosalind Ramsey-Goldman, Ian N Bruce, Guillermo Ruiz-Irastorza, Ellen M Ginzler, Graciela S Alarcón, John G Hanly, Murray B Urowitz, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Anisur Rahman, Mary Anne Dooley, Paul R Fortin, Meggan Mackay, Andreas Jönsen, Sam Lim, Murat Inanc, Diane L Kamen, Christine A Peschken, Søren Jacobsen, Jorge Sanchez-Guerrero, David Isenberg, Marvin J Fritzler, Ann E Clarke, Sasha Bernatsky, Kenneth C Kalunian, Eugene Krustev, May Y Choi, Katherine A Buhler, Ricky Chin

Get full text

2021 DORIS definition of remission in SLE: final recommendations from an international task force by Victoria P Werth, Ronald F van Vollenhoven, Andrea Doria, Matthias Schneider, Marta Mosca, Nathalie Costedoat-Chalumeau, Cynthia Aranow, Ian N Bruce, Dimitrios T Boumpas, Michael M Ward, Manuel Francisco Ugarte-Gil, Bernardo A Pons-Estel, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Anisur Rahman, Murat Inanc, Søren Jacobsen, George Bertsias, Xavier Mariette, Thomas Dörner, Hendrika Bootsma, Josef Smolen, David Jayne, Martin Aringer, David Isenberg, László Czirják, Y K Onno Teng, Frédéric A Houssiau, Hermine Brunner, Eric Morand, Carlos Vasconcelos, Guillermo Pons-Estel, Graciela Alarcon, Eloisa Bonfa, Alexandre Voskuyl, Raquel Faria, Anne Voss, Maarten Limper, Anca D Askanase, Sandra Navarra, Cindy Coney, Ruth Fritsch-Stork, Bernadette van Leeuw, Michel Tsang-a-Sjoe, Rebecca Fischer, Marzena Helena Olesinska, Blanca Rubio, Yehuda Schoenfeld, Elena Zakharhova

Get full text

Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies by Ronald F van Vollenhoven, Laurent Arnaud, Marta Mosca, Nathalie Costedoat-Chalumeau, Elisabet Svenungsson, Daniel J Wallace, Judith A James, Kenneth Kalunian, Susan Manzi, Michelle A Petri, Jill Buyon, Rosalind Ramsey-Goldman, Ian N Bruce, Guillermo Ruiz-Irastorza, Ellen M Ginzler, Manuel Francisco Ugarte-Gil, Bernardo A Pons-Estel, Juanita Romero-Diaz, Sang-Cheol Bae, Anisur Rahman, Paul R Fortin, Dafna D Gladman, Andreas Jönsen, Murat Inanc, Diane L Kamen, Søren Jacobsen, Jorge Sanchez-Guerrero, Évelyne Vinet, Murray Urowitz, David Isenberg, Sasha Bernatsky, John Reynolds, Eric Morand, Vernon Farewell, Claudia Elera-Fitzcarrald, Cristina Reátegui-Sokolova, Alexandre Voskuyl, Anca D Askanase, John Hanly, Anselm Mak, Sung Sam Lim, Christine Peschken, Graciela S. Alarcon, Joanna Leong, Bhushan Dharmadhikari, Nien Yee Kow, Cinthia Aranow, Mary Ann Dooley, Mike Cheung

Get full text